The 2019 Award finalists

Consultancy of the year

View the finalists

Consultancy of the year

  • Bain & Company
  • Healthcare Consulting Services(HCS)
  • Inova Care
  • IQVIA
  • L.E.K Consulting
  • Oliver Wyman
Attending the awards

Law firm of the year

View the finalists

Law firm of the year

  • RHTLaw Taylor Wessing
  • Baker McKenzie
  • Drew & Napier
  • Stephenson Harwood
Attending the awards

Primary care deal of the year

View the finalists

Primary care deal of the year

  • Digital platform HaloDoc raises $65m 
  • Fullerton acquires majority stake in Global Doctor 
  • WeDoctor / Greater Bay Area initiative
Attending the awards

Multi-site operator deal of the year

View the finalists

Multi-site operator deal of the year

  • SMG enters Australia fertility market
  • Warburg Pincus and CNCB close financing round for Jinxin Fertility 
Attending the awards

Health infrastructure/Property deal of the year

View the finalists

Health infrastructure/Property deal of the year

  • Kendall Court invests $55m in Mandaya Medical International
  • OUE Lippo's acquisition of First REIT
Attending the awards

Acute/Secondary care deal of the year

View the finalists

Acute/Secondary care deal of the year

  • DBS Bank: Medikaloka Hermina floats on the Indonesia Stock Exchange
  • General Atlantic invests $150m in Asia Medical
  • IHH becomes controlling shareholder in Fortis
Attending the awards

Corporate finance team of the year

View the finalists

Corporate finance team of the year

  • DBS Bank
  • CICC
  • OCBC
Attending the awards

Investor of the year

View the finalists

Investor of the year

  • Health Management International
  • HealthX Capital
  • Quadria Capital
  • Southern Capital Group
Attending the awards

Diagnostics deal of the year

View the finalists

Diagnostics deal of the year

  • Actis sells stake in Chemclin for US$150m
  • Ark's $40m Series A fund raise
  • GE Healthcare's $16M deal with Mayapada Healthcare
  • X-ZELL's partnership with Singapore’s Diagnostics Development (DxD) Hub
Attending the awards

About HealthInvestor Asia

HealthInvestor Asia (HIA) is the definitive source of financial intelligence for Apac’s growing healthcare markets. 

HIA’s dedicated coverage of corporate and capital market activity in the healthcare sector provides independent and authoritative insight for investors, lenders, advisors and healthcare firms operating across the region. 

By focusing specifically on the health sector, HIA provides forensic analysis of this vital and growing market. 

HIA’s market-leading editorial coverage enables readers to grasp the complexities of the region and follow the flow of investment across health systems in Asia. Its market commentary and analysis is an invaluable tool in identifying trends and opportunities and its focused reporting allows readers to keep up to date with this fast-moving and exciting sector.